Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery

被引:0
作者
Li, Qingxin [1 ]
Kang, Congbao [2 ]
机构
[1] Guangdong Acad Sci, Inst Biol & Med Engn, Guangdong Prov Engn Lab Biomass High Value Utiliza, Guangzhou 510316, Peoples R China
[2] ASTAR, Expt Drug Dev Ctr EDDC, 10 Biopolis Rd,05-01, Singapore 138670, Singapore
来源
MOLECULES | 2024年 / 29卷 / 23期
关键词
F-19-NMR; fragment screening; drug discovery; fragment-based drug design; in-cell F-19-NMR; OBSERVED FLUORINE NMR; PROTEIN-PROTEIN INTERACTIONS; LIGAND BINDING; STD NMR; RNA; SPECTROSCOPY; IDENTIFICATION; TOOL; QUANTIFICATION; VALIDATION;
D O I
10.3390/molecules29235748
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fragment-based drug discovery is a powerful approach in drug discovery, applicable to a wide range of targets. This method enables the discovery of potent compounds that can modulate target functions, starting from fragment compounds that bind weakly to the targets. While biochemical, biophysical, and cell-based assays are commonly used to identify fragments, F-19-NMR spectroscopy has emerged as a powerful tool for exploring interactions between biomolecules and ligands. Because fluorine atoms are not naturally present in biological systems, F-19-NMR serves as a sensitive method for fragment screening against diverse targets. Herein, we reviewed the applications of F-19-NMR in fragment screening, highlighting its effectiveness in identifying fragments that bind weakly to various targets such as proteins and RNA. The accumulated evidence suggests that F-19-NMR will continue to be a crucial tool in drug discovery.
引用
收藏
页数:16
相关论文
共 133 条
  • [1] Ranking Hits From Saturation Transfer Difference Nuclear Magnetic Resonance-Based Fragment Screening
    Aretz, Jonas
    Rademacher, Christoph
    [J]. FRONTIERS IN CHEMISTRY, 2019, 7
  • [2] Allosteric Inhibition of a Mammalian Lectin
    Aretz, Jonas
    Anumala, Upendra R.
    Fuchsberger, Felix F.
    Molavi, Narges
    Ziebart, Nandor
    Zhang, Hengxi
    Nazare, Marc
    Rademacher, Christoph
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (44) : 14915 - 14925
  • [3] Protein-Observed Fluorine NMR: A Bioorthogonal Approach for Small Molecule Discovery
    Arntson, Keith E.
    Pomerantz, William C. K.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (11) : 5158 - 5171
  • [4] Quantifying Siglec-sialylated ligand interactions: a versatile 19F-T2 CPMG filtered competitive NMR displacement assay
    Atxabal, Unai
    Fernandez, Andrea
    Moure, Maria Jesus
    Sobczak, Klaudia
    Nycholat, Corwin
    Almeida-Marrero, Veronica
    Oyenarte, Iker
    Paulson, James C.
    de la Escosura, Andres
    Torres, Tomas
    Reichardt, Niels C.
    Jimenez-Barbero, Jesus
    Ereno-Orbea, June
    [J]. CHEMICAL SCIENCE, 2024, 15 (27) : 10612 - 10624
  • [5] Practical Considerations and Guidelines for Spectral Referencing for Fluorine NMR Ligand Screening
    Ayotte, Yann
    Woo, Simon
    LaPlante, Steven R.
    [J]. ACS OMEGA, 2022, 7 (15): : 13155 - 13163
  • [6] Development of potent inhibitors by fragment-linking strategies
    Bedwell, Elizabeth, V
    McCarthy, William J.
    Coyne, Anthony G.
    Abell, Chris
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2022, 100 (04) : 469 - 486
  • [7] NMR-based Fragment Screening in a Minimum Sample but Maximum Automation Mode
    Berg, Hannes
    Martin, M. A. Wirtz
    Niesteruk, A.
    Richter, C.
    Sreeramulu, S.
    Schwalbe, H.
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (172):
  • [8] 19F NMR-Based Fragment Screening for 14 Different Biologically Active RNAs and 10 DNA and Protein Counter-Screens
    Binas, Oliver
    de Jesus, Vanessa
    Landgraf, Tom
    Voelklein, Albrecht Eduard
    Martins, Jason
    Hymon, Daniel
    Kaur Bains, Jasleen
    Berg, Hannes
    Biedenbaender, Thomas
    Fuertig, Boris
    Lakshmi Gande, Santosh
    Niesteruk, Anna
    Oxenfarth, Andreas
    Shahin Qureshi, Nusrat
    Schamber, Tatjana
    Schnieders, Robbin
    Troester, Alix
    Wacker, Anna
    Wirmer-Bartoschek, Julia
    Wirtz Martin, Maria Alexandra
    Stirnal, Elke
    Azzaoui, Kamal
    Richter, Christian
    Sreeramulu, Sridhar
    Jose Blommers, Marcel Jules
    Schwalbe, Harald
    [J]. CHEMBIOCHEM, 2021, 22 (02) : 423 - 433
  • [9] Fluorine in medicinal chemistry
    Böhm, HJ
    Banner, D
    Bendels, S
    Kansy, M
    Kuhn, B
    Müller, K
    Obst-Sander, U
    Stahl, M
    [J]. CHEMBIOCHEM, 2004, 5 (05) : 637 - 643
  • [10] Fragment-based drug discovery-the importance of high-quality molecule libraries
    Bon, Marta
    Bilsland, Alan
    Bower, Justin
    McAulay, Kirsten
    [J]. MOLECULAR ONCOLOGY, 2022, 16 (21) : 3761 - 3777